Market Overview
The global vascular access device market size was valued at USD 6.02 billion in 2024. The market is projected to grow from USD 6.49 billion in 2025 to USD 13.65 billion by 2034, exhibiting a CAGR of 7.7% during 2025–2034.
Key market dynamics are driven by rising prevalence of chronic diseases requiring long-term infusion, expanding ambulatory and home infusion capabilities, higher procedural volumes for advanced therapies, and institutional priorities to reduce catheter-related complications. Technological advances in insertion guidance (e.g., ultrasound), antimicrobial or anti-biofilm coatings, improved securement and closed-system connectors are raising clinical expectations for performance and safety. At the same time, service models that bundle devices with training, vascular access teams and telehealth monitoring are reshaping value propositions away from unit pricing toward outcomes-based procurement.
Market Scope
- Device and Consumable Coverage — The market covers a broad set of devices: central venous access systems (PICC, tunneled/non-tunneled catheters, implantable ports), peripheral vascular devices (PIVCs, midlines), arterial catheters, intraosseous access kits, and complementary consumables such as extension tubing, needleless connectors, dressings, and securement systems.
- Care Settings End Users — Demand originates from hospitals (ICUs, oncology, emergency departments), ambulatory surgery and infusion centers, dialysis clinics, long-term care facilities, and home healthcare providers. Growth in outpatient infusion and home administration of biologics and chemotherapies is expanding the addressable market.
- Value Chain Components — Scope includes device manufacturers, distributors, procurement organizations, contract sterilizers and reprocessing services (where applicable), training and procedural support vendors, and healthcare systems implementing vascular access teams and credentialing programs.
- Measurement Time Frame — Typical market metrics include device unit shipments, revenue (USD), procedure volumes (e.g., infusion episodes, catheterizations), complication and replacement rates, and forecasts across short-term (3 years) and medium-term (5–10 years) horizons to capture both replacement cycles and structural demand shifts.
Market Opportunities
- Outpatient and Home Infusion Expansion
The shift of infusion therapies to ambulatory and home settings is a major growth vector. Devices optimized for outpatient insertion, simplified maintenance, patient comfort, and compatibility with home nursing and telemonitoring are in demand. Suppliers that design for user friendliness and remote support can capture share as payers encourage lower-cost care settings. - Infection Prevention and Quality Programs
Reducing catheter-related bloodstream infections (CRBSIs) and other complications represents both a clinical imperative and an economic opportunity. Devices with integrated safety features (antimicrobial coatings, closed systems), combined with insertion bundles and monitoring solutions, appeal to institutions focused on quality outcomes and value-based purchasing. - Procedural Efficiency and Workforce Enablement
Solutions that shorten procedure time, increase first-attempt success, and reduce the need for replacement insertions are highly valued amid workforce shortages. Integration with ultrasound guidance, standardized kits, and training programs for vascular access teams improve adoption and create service-based revenue models beyond device sales. - Connected Devices and Service Platforms
Adjacent markets for sensors, remote condition monitoring, inventory analytics and procedural training represent opportunities to move from commodity device sales to platform offerings. Bundling devices with analytics and managed services can stabilize revenue and demonstrate measurable reductions in complications and total cost of care.
List of Key Companies in Vascular Access Device Market
- B. Braun Melsungen AG
- C.R. Bard (acquired by Medtronic)
- Cook Medical
- Terumo Corporation
- Smiths Medical
- Medtronic
- Abbott Laboratories
- Teleflex Incorporated
- AngioDynamics
- Fresenius Medical Care
- Johnson Johnson
- ICU Medical
- Vygon SA
- ConvaTec Group
- Becton, Dickinson and Company
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/vascular-access-device-market
Regional Analysis
- North America
A mature market with high per-capita procedure volumes and advanced adoption of specialty vascular access devices and procedural protocols. Strong home-infusion infrastructure, widespread use of vascular access teams, and focus on infection prevention drive demand for quality devices and bundled services. - Europe
Characterized by broad institutional adoption of safety-oriented products and progressive outpatient care models in many countries. Regulatory rigor and emphasis on evidence-based device selection encourage uptake of devices with demonstrated clinical benefit. Market maturity varies between Western and Eastern Europe, influencing purchase patterns. - Asia-Pacific
The fastest-growing region by volume, powered by investments in hospital capacity, expanding oncology and dialysis services, and growing awareness of advanced infusion therapies. Market heterogeneity is significant: advanced economies adopt premium solutions faster, while emerging markets prioritize cost-effective, scalable options and workforce training. - Latin America
Growth reflects expanding private healthcare, urbanization and investments in hospital upgrades. Budget constraints and variable reimbursement mean adoption tends to favor cost-effective alternatives, although metropolitan centers often procure advanced solutions aligned with international standards. - Middle East Africa (MEA)
Adoption is concentrated in urban centers and major healthcare projects where speed and quality are prioritized. Broader regional uptake hinges on investments in local clinician training, supply chain infrastructure, and regulatory harmonization.
Trends, Risks and Strategic Considerations
- Evidence and Outcomes: Adoption increasingly depends on rigorous clinical data demonstrating reductions in complications and overall cost savings. Manufacturers and service providers should prioritize clinical trials, post-market registries and real-world evidence generation.
- Training Standardization: The performance benefits of advanced devices are realized only when insertion and maintenance are standardized. Offering bundled training, competency programs and vascular access team support enhances device value and reduces adoption resistance.
- Supply Chain Resilience Cost Management: Manufacturers must manage variability in raw material and sterilization costs and invest in flexible manufacturing or regional production to minimize logistics challenges and maintain service levels.
- Regulatory Reimbursement Navigation: Tailored regulatory strategies and local market evidence are essential for market entry and pricing. Engagement with payers to demonstrate total cost of ownership improvements will support uptake of higher-value devices.
Conclusion Outlook
The Vascular Access Device Market is transitioning toward an integrated, outcome-oriented ecosystem in which devices, training, services and data combine to deliver measurable clinical and economic benefits. Growth will be fueled by expanding infusion therapy volumes, migration of care to outpatient and home settings, and a sustained institutional focus on infection prevention and procedural efficiency. Market winners will be those that pair clinically validated products with robust training, procedural support and service platforms that demonstrate reproducible improvements in patient outcomes and cost metrics.
As healthcare systems globally balance cost containment with quality imperatives, devices and providers that can clearly document reduced complication rates, improved procedural efficiency and compatibility with digital workflows will capture the largest share of future growth. Continued investment in clinical evidence, workforce enablement and supply-chain resilience will be critical to realizing the full potential of vascular access innovations worldwide.
More Trending Latest Reports By Polaris Market Research:
solar inverter pv inverter market
